| 1 | Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation | 4.7 | 11 | Citations (PDF) |
| 2 | Encrypted federated learning for secure decentralized collaboration in cancer image analysis | 10.6 | 61 | Citations (PDF) |
| 3 | Genome-Wide Gene–Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk | 1.2 | 13 | Citations (PDF) |
| 4 | Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature | 1.2 | 1 | Citations (PDF) |
| 5 | Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk | 5.7 | 10 | Citations (PDF) |
| 6 | Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the <scp>COVID‐19</scp> pandemic | 4.5 | 3 | Citations (PDF) |
| 7 | The underestimated preventive effects of flexible sigmoidoscopy screening: re-analysis and meta-analysis of randomized trials | 6.1 | 6 | Citations (PDF) |
| 8 | Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes | 13.9 | 15 | Citations (PDF) |
| 9 | Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018–2020 | 7.4 | 30 | Citations (PDF) |
| 10 | Excess Weight, Polygenic Risk Score, and Findings of Colorectal Neoplasms at Screening Colonoscopy | 0.7 | 5 | Citations (PDF) |
| 11 | Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology | 6.7 | 25 | Citations (PDF) |
| 12 | Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer | 11.0 | 5 | Citations (PDF) |
| 13 | Prognostic value of post-operative iron biomarkers in colorectal cancer: population-based patient cohort | 5.7 | 3 | Citations (PDF) |
| 14 | Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood | 6.7 | 3 | Citations (PDF) |
| 15 | Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection | 6.7 | 7 | Citations (PDF) |
| 16 | Polygenic Risk Score for Defining Personalized Surveillance Intervals After Adenoma Detection and Removal at Colonoscopy | 6.2 | 16 | Citations (PDF) |
| 17 | Making colonoscopy‐based screening more efficient: A “gateopener” approach | 4.5 | 4 | Citations (PDF) |
| 18 | Body mass index and molecular subtypes of colorectal cancer | 4.7 | 27 | Citations (PDF) |
| 19 | Validation of the prognostic value of <scp>CD3</scp> and <scp>CD8</scp> cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study | 3.4 | 16 | Citations (PDF) |
| 20 | Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort | 1.2 | 5 | Citations (PDF) |
| 21 | Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response | 1.2 | 4 | Citations (PDF) |
| 22 | Breast cancer screening programmes and self‐reported mammography use in <scp>European</scp> countries | 4.5 | 21 | Citations (PDF) |
| 23 | A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk | 0.6 | 11 | Citations (PDF) |
| 24 | Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis | 2.9 | 11 | Citations (PDF) |
| 25 | Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci | 1.2 | 2 | Citations (PDF) |
| 26 | Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses | 5.7 | 12 | Citations (PDF) |
| 27 | Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients | 4.5 | 3 | Citations (PDF) |
| 28 | Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations | 13.9 | 20 | Citations (PDF) |
| 29 | Association of Comedication Quality With Chemotherapy-Related Adverse Drug Reactions and Survival in Older Colorectal Cancer Patients | 3.5 | 4 | Citations (PDF) |
| 30 | Weakly supervised annotation‐free cancer detection and prediction of genotype in routine histopathology | 5.0 | 77 | Citations (PDF) |
| 31 | Model based evaluation of <scp>long‐term</scp> efficacy of existing and alternative colorectal cancer screening offers: A case study for Germany | 4.5 | 16 | Citations (PDF) |
| 32 | Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival | 3.5 | 15 | Citations (PDF) |
| 33 | Variation of positive predictive values of fecal immunochemical tests by polygenic risk score in a large screening cohort | 2.9 | 4 | Citations (PDF) |
| 34 | Genetic variants associated with circulating C‐reactive protein levels and colorectal cancer survival: Sex‐specific and lifestyle factors specific associations | 4.5 | 5 | Citations (PDF) |
| 35 | Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study | 4.7 | 25 | Citations (PDF) |
| 36 | Wirksamkeit von Screeningprogrammen | 0.2 | 0 | Citations (PDF) |
| 37 | Risk of Colorectal Cancer Associated With Lifetime Excess Weight | 14.6 | 36 | Citations (PDF) |
| 38 | Red and Processed Meat Intake, Polygenic Risk Score, and Colorectal Cancer Risk | 4.7 | 13 | Citations (PDF) |
| 39 | Associations of Body Mass Index at Different Ages With Early-Onset Colorectal Cancer | 1.0 | 93 | Citations (PDF) |
| 40 | Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases | 4.5 | 10 | Citations (PDF) |
| 41 | Higher vitamin B6 status is associated with improved survival among patients with stage I–III colorectal cancer | 4.9 | 16 | Citations (PDF) |
| 42 | Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy | 1.2 | 14 | Citations (PDF) |
| 43 | Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region | 1.2 | 14 | Citations (PDF) |
| 44 | Incorporation of functional status, frailty, comorbidities and comedication in prediction models for colorectal cancer survival | 4.5 | 10 | Citations (PDF) |
| 45 | Swarm learning for decentralized artificial intelligence in cancer histopathology | 39.5 | 176 | Citations (PDF) |
| 46 | Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk | 4.7 | 4 | Citations (PDF) |
| 47 | Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study | 23.6 | 40 | Citations (PDF) |
| 48 | Benchmarking weakly-supervised deep learning pipelines for whole slide classification in computational pathology | 10.6 | 137 | Citations (PDF) |
| 49 | Alcohol consumption, polygenic risk score, and early- and late-onset colorectal cancer risk | 8.5 | 40 | Citations (PDF) |
| 50 | Reproductive factors and colorectal cancer risk: A Population-based case-control study | 3.0 | 7 | Citations (PDF) |
| 51 | Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using
tumor mutational signatures | 13.9 | 25 | Citations (PDF) |
| 52 | Combined Performance of Fecal Immunochemical Tests and a Genetic Risk Score for Advanced Neoplasia Detection | 1.5 | 5 | Citations (PDF) |
| 53 | Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study | 7.4 | 16 | Citations (PDF) |
| 54 | Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany | 4.0 | 8 | Citations (PDF) |
| 55 | Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis | 1.2 | 4 | Citations (PDF) |
| 56 | Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries | 26.1 | 194 | Citations (PDF) |
| 57 | Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants | 4.7 | 20 | Citations (PDF) |
| 58 | The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance | 4.5 | 87 | Citations (PDF) |
| 59 | Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects | 1.0 | 60 | Citations (PDF) |
| 60 | Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients | 3.8 | 9 | Citations (PDF) |
| 61 | Lack of an association between gallstone disease and bilirubin levels with risk of colorectal cancer: a Mendelian randomisation analysis | 5.7 | 9 | Citations (PDF) |
| 62 | Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History | 3.0 | 3 | Citations (PDF) |
| 63 | Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany | 0.7 | 61 | Citations (PDF) |
| 64 | Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model | 4.5 | 26 | Citations (PDF) |
| 65 | Genetic architectures of proximal and distal colorectal cancer are partly distinct | 21.2 | 71 | Citations (PDF) |
| 66 | Smoking, Genetic Predisposition, and Colorectal Cancer Risk | 2.9 | 34 | Citations (PDF) |
| 67 | Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortium | 4.9 | 17 | Citations (PDF) |
| 68 | The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity | 4.9 | 9 | Citations (PDF) |
| 69 | Individual and Joint Associations of Genetic Risk and Healthy Lifestyle Score with Colorectal Neoplasms Among Participants of Screening Colonoscopy | 1.5 | 6 | Citations (PDF) |
| 70 | Response to Li and Hopper | 6.5 | 5 | Citations (PDF) |
| 71 | The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials | 4.0 | 31 | Citations (PDF) |
| 72 | Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts | 4.0 | 6 | Citations (PDF) |
| 73 | Second-generation colon capsule endoscopy for detection of colorectal polyps: Systematic review and meta-analysis of clinical trials | 1.7 | 23 | Citations (PDF) |
| 74 | Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer | 3.0 | 66 | Citations (PDF) |
| 75 | Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study | 1.2 | 8 | Citations (PDF) |
| 76 | Association between Smoking and Molecular Subtypes of Colorectal Cancer | 3.0 | 17 | Citations (PDF) |
| 77 | DNA Methylation-Based Estimates of Circulating Leukocyte Composition for Predicting Colorectal Cancer Survival: A Prospective Cohort Study | 4.0 | 5 | Citations (PDF) |
| 78 | Non‐steroidal anti‐inflammatory drugs, polygenic risk score and colorectal cancer risk | 3.9 | 21 | Citations (PDF) |
| 79 | Inpatient rehabilitation therapy among colorectal cancer patients – utilization and association with prognosis: a cohort study | 1.8 | 6 | Citations (PDF) |
| 80 | Risk Factors of Inadequate Bowel Preparation for Screening Colonoscopy | 2.6 | 24 | Citations (PDF) |
| 81 | Association of Body Mass Index With Risk of Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis | 0.7 | 100 | Citations (PDF) |
| 82 | To what extent is male excess risk of advanced colorectal neoplasms explained by known risk factors? Results from a large German screening population | 4.5 | 9 | Citations (PDF) |
| 83 | Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study | 26.0 | 376 | Citations (PDF) |
| 84 | Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening | 4.0 | 10 | Citations (PDF) |
| 85 | Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies | 3.0 | 19 | Citations (PDF) |
| 86 | Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review | 5.1 | 156 | Citations (PDF) |
| 87 | Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients | 3.5 | 15 | Citations (PDF) |
| 88 | Characteristics of Early-Onset vs Late-Onset Colorectal Cancer | 9.1 | 235 | Citations (PDF) |
| 89 | Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics | 2.9 | 12 | Citations (PDF) |
| 90 | A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer | 1.2 | 18 | Citations (PDF) |
| 91 | Deep learning can predict lymph node status directly from histology in colorectal cancer | 5.1 | 64 | Citations (PDF) |
| 92 | Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study | 4.7 | 8 | Citations (PDF) |
| 93 | Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation | 2.4 | 5 | Citations (PDF) |
| 94 | DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility | 4.5 | 45 | Citations (PDF) |
| 95 | Meta‐analysis of 16 studies of the association of alcohol with colorectal cancer | 4.5 | 138 | Citations (PDF) |
| 96 | Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study | 4.5 | 24 | Citations (PDF) |
| 97 | Establishing a valid approach for estimating familial risk of cancer explained by common genetic variants | 4.5 | 7 | Citations (PDF) |
| 98 | Effect of long-term frozen storage and thawing of stool samples on faecal haemoglobin concentration and diagnostic performance of faecal immunochemical tests | 2.4 | 7 | Citations (PDF) |
| 99 | Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium | 4.5 | 39 | Citations (PDF) |
| 100 | Modifiable pathways for colorectal cancer: a mendelian randomisation analysis | 23.6 | 119 | Citations (PDF) |
| 101 | Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer | 1.0 | 168 | Citations (PDF) |
| 102 | Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses | 1.0 | 119 | Citations (PDF) |
| 103 | Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study | 4.2 | 25 | Citations (PDF) |
| 104 | Prevalence of a First-Degree Relative With Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old | 6.2 | 16 | Citations (PDF) |
| 105 | Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies | 9.8 | 7 | Citations (PDF) |
| 106 | Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study | 1.2 | 24 | Citations (PDF) |
| 107 | Association of BMI and major molecular pathological markers of colorectal cancer in men and women | 4.9 | 23 | Citations (PDF) |
| 108 | Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location | 3.0 | 18 | Citations (PDF) |
| 109 | Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival | 3.0 | 19 | Citations (PDF) |
| 110 | Self-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries | 2.9 | 1 | Citations (PDF) |
| 111 | Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival | 13.9 | 75 | Citations (PDF) |
| 112 | Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk | 1.2 | 3 | Citations (PDF) |
| 113 | Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation | 8.5 | 22 | Citations (PDF) |
| 114 | Whole blood DNA methylation aging markers predict colorectal cancer survival: a prospective cohort study | 4.0 | 18 | Citations (PDF) |
| 115 | Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk | 6.5 | 187 | Citations (PDF) |
| 116 | Pan-cancer image-based detection of clinically actionable genetic alterations | 22.8 | 536 | Citations (PDF) |
| 117 | Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients | 4.5 | 14 | Citations (PDF) |
| 118 | Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses | 7.5 | 43 | Citations (PDF) |
| 119 | Age‐dependent performance of <scp><i>BRAF</i></scp> mutation testing in Lynch syndrome diagnostics | 4.5 | 29 | Citations (PDF) |
| 120 | Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies | 0.6 | 42 | Citations (PDF) |
| 121 | Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study | 7.5 | 143 | Citations (PDF) |
| 122 | Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study | 0.7 | 23 | Citations (PDF) |
| 123 | Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis | 1.6 | 3 | Citations (PDF) |
| 124 | Genotype-Based Gene Expression in Colon Tissue—Prediction Accuracy and Relationship with the Prognosis of Colorectal Cancer Patients | 4.5 | 4 | Citations (PDF) |
| 125 | Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice | 2.9 | 16 | Citations (PDF) |
| 126 | New insights into the association of meat intake and sessile serrated lesions of the large bowel | 4.9 | 0 | Citations (PDF) |
| 127 | Physical activity and long-term fatigue among colorectal cancer survivors – a population-based prospective study | 3.1 | 12 | Citations (PDF) |
| 128 | Use of Polygenic Risk Scores to Select Screening Intervals After Negative Findings From Colonoscopy | 6.2 | 20 | Citations (PDF) |
| 129 | Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey | 4.0 | 89 | Citations (PDF) |
| 130 | Blood‐derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs | 4.2 | 11 | Citations (PDF) |
| 131 | Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning | 1.0 | 317 | Citations (PDF) |
| 132 | Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk | 1.2 | 35 | Citations (PDF) |
| 133 | Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk | 2.7 | 9 | Citations (PDF) |
| 134 | Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-Based Study | 1.0 | 100 | Citations (PDF) |
| 135 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers | 13.9 | 118 | Citations (PDF) |
| 136 | Risk-Adapted Cutoffs in Colorectal Cancer Screening by Fecal Immunochemical Tests | 0.7 | 11 | Citations (PDF) |
| 137 | Messung der körperlichen Fitness in der NAKO Gesundheitsstudie – Methoden, Qualitätssicherung und erste deskriptive Ergebnisse | 1.4 | 4 | Citations (PDF) |
| 138 | Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies | 1.0 | 43 | Citations (PDF) |
| 139 | Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways | 4.5 | 16 | Citations (PDF) |
| 140 | Association of laparoscopic colectomy versus open colectomy on the long-term health-related quality of life of colon cancer survivors | 2.4 | 6 | Citations (PDF) |
| 141 | Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways | 5.7 | 81 | Citations (PDF) |
| 142 | Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients | 4.5 | 40 | Citations (PDF) |
| 143 | Genetic Predictors of Circulating 25-Hydroxyvitamin D and Prognosis after Colorectal Cancer | 1.2 | 1 | Citations (PDF) |
| 144 | Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study | 1.5 | 11 | Citations (PDF) |
| 145 | Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort | 1.9 | 3 | Citations (PDF) |
| 146 | Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis | 13.9 | 547 | Citations (PDF) |
| 147 | Low Risk of Advanced Neoplasms for up to 20 Years After Negative Colonoscopy Result: Potential for Personalized Follow-up Screening Intervals | 1.0 | 9 | Citations (PDF) |
| 148 | Vascular injury biomarkers and stroke risk | 1.0 | 14 | Citations (PDF) |
| 149 | Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial | 1.3 | 2 | Citations (PDF) |
| 150 | Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial | 1.3 | 0 | Citations (PDF) |
| 151 | Genetic Variants in the Regulatory T cell–Related Pathway and Colorectal Cancer Prognosis | 1.2 | 4 | Citations (PDF) |
| 152 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer | 4.7 | 155 | Citations (PDF) |
| 153 | The Association Between Mutations in BRAF and Colorectal Cancer–Specific Survival Depends on Microsatellite Status and Tumor Stage | 6.2 | 76 | Citations (PDF) |
| 154 | External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS | 3.1 | 23 | Citations (PDF) |
| 155 | A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival | 4.0 | 4 | Citations (PDF) |
| 156 | Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening | 0.7 | 38 | Citations (PDF) |
| 157 | Leserbrief zum Beitrag: „Gesunde Lebensführung reduziert KRK-Risiko“ | 0.3 | 0 | Citations (PDF) |
| 158 | Personalizing the Prediction of Colorectal Cancer Prognosis by Incorporating Comorbidities and Functional Status into Prognostic Nomograms | 4.0 | 25 | Citations (PDF) |
| 159 | <p>Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses</p> | 2.9 | 14 | Citations (PDF) |
| 160 | Thrombomodulin and Thrombopoietin, Two Biomarkers of Hemostasis, Are Positively Associated with Adherence to the World Cancer Research Fund/American Institute for Cancer Research Recommendations for Cancer Prevention in a Population-Based Cross-Sectional Study | 4.7 | 3 | Citations (PDF) |
| 161 | Plasma metabolites associated with colorectal cancer: A discovery‐replication strategy | 4.5 | 53 | Citations (PDF) |
| 162 | Shared heritability and functional enrichment across six solid cancers | 13.9 | 106 | Citations (PDF) |
| 163 | Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study | 8.5 | 890 | Citations (PDF) |
| 164 | Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer | 39.5 | 1,224 | Citations (PDF) |
| 165 | Association analyses identify 31 new risk loci for colorectal cancer susceptibility | 13.9 | 218 | Citations (PDF) |
| 166 | Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003–2016 | 2.9 | 16 | Citations (PDF) |
| 167 | Plasma Fibrinogen and sP-Selectin are Associated with the Risk of Lung Cancer in a Prospective Study | 1.2 | 20 | Citations (PDF) |
| 168 | Serum Concentration of Genistein, Luteolin and Colorectal Cancer Prognosis | 4.7 | 17 | Citations (PDF) |
| 169 | Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer | 3.1 | 15 | Citations (PDF) |
| 170 | Optimal age for screening colonoscopy: a modeling study | 1.9 | 34 | Citations (PDF) |
| 171 | Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer | 3.0 | 50 | Citations (PDF) |
| 172 | Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer | 1.0 | 149 | Citations (PDF) |
| 173 | Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification | 2.9 | 4 | Citations (PDF) |
| 174 | Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies | 2.6 | 48 | Citations (PDF) |
| 175 | Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis | 1.5 | 27 | Citations (PDF) |
| 176 | Biomarkers of Vascular Injury and Type 2 Diabetes: A Prospective Study, Systematic Review and Meta-Analysis | 2.6 | 10 | Citations (PDF) |
| 177 | DNA Methylation Profiling to Explore Colorectal Tumor Differences According to Menopausal Hormone Therapy Use in Women | 2.3 | 4 | Citations (PDF) |
| 178 | Utilization and determinants of follow‐up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study | 4.5 | 14 | Citations (PDF) |
| 179 | Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study | 4.5 | 11 | Citations (PDF) |
| 180 | Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis | 6.2 | 10 | Citations (PDF) |
| 181 | Strong associations of a healthy lifestyle with all stages of colorectal carcinogenesis: Results from a large cohort of participants of screening colonoscopy | 4.5 | 28 | Citations (PDF) |
| 182 | Mendelian randomization analysis of C-reactive protein on colorectal cancer risk | 5.1 | 45 | Citations (PDF) |
| 183 | Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes | 4.7 | 37 | Citations (PDF) |
| 184 | A Web-based survey among adults aged 40–54 years was time effective and yielded stable response patterns | 3.7 | 7 | Citations (PDF) |
| 185 | Time of Metastasis and Outcome in Colorectal Cancer | 4.7 | 38 | Citations (PDF) |
| 186 | Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier) | 21.2 | 37 | Citations (PDF) |
| 187 | Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review | 6.2 | 47 | Citations (PDF) |
| 188 | Dietary patterns and risk of advanced colorectal neoplasms: A large population based screening study in Germany | 2.9 | 17 | Citations (PDF) |
| 189 | Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors | 1.0 | 268 | Citations (PDF) |
| 190 | Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis | 9.8 | 186 | Citations (PDF) |
| 191 | Fecal immunochemical tests in combination with blood tests for colorectal cancer and advanced adenoma detection—systematic review | 5.0 | 19 | Citations (PDF) |
| 192 | Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population | 2.9 | 13 | Citations (PDF) |
| 193 | A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics | 6.5 | 31 | Citations (PDF) |
| 194 | Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States | 1.9 | 39 | Citations (PDF) |
| 195 | Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study | 2.5 | 66 | Citations (PDF) |
| 196 | Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk | 1.0 | 132 | Citations (PDF) |
| 197 | Accuracy of a fecal immunochemical test according to outside temperature and travel time | 2.9 | 10 | Citations (PDF) |
| 198 | Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer | 5.7 | 19 | Citations (PDF) |
| 199 | Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer | 2.4 | 9 | Citations (PDF) |
| 200 | Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis | 4.7 | 77 | Citations (PDF) |
| 201 | How long does it take until the effects of endoscopic screening on colorectal cancer mortality are fully disclosed?: a Markov model study | 4.5 | 29 | Citations (PDF) |
| 202 | Dose-Response Relationship between Serum Retinol Levels and Survival in Patients with Colorectal Cancer: Results from the DACHS Study | 4.7 | 10 | Citations (PDF) |
| 203 | Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies | 6.1 | 20 | Citations (PDF) |
| 204 | Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score | 2.9 | 78 | Citations (PDF) |
| 205 | Potential determinants of physical inactivity among long-term colorectal cancer survivors | 2.1 | 15 | Citations (PDF) |
| 206 | Pathway analysis of genetic variants in folate‐mediated one‐carbon metabolism‐related genes and survival in a prospectively followed cohort of colorectal cancer patients | 2.7 | 21 | Citations (PDF) |
| 207 | Discovery of common and rare genetic risk variants for colorectal cancer | 26.1 | 499 | Citations (PDF) |
| 208 | Pre‐diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP‐selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study | 4.5 | 14 | Citations (PDF) |
| 209 | Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk | 0.6 | 32 | Citations (PDF) |
| 210 | Screening colonoscopy volume and detection of colorectal neoplasms: a state-wide study from Bavaria, Germany | 2.1 | 7 | Citations (PDF) |
| 211 | Plasma 25-Hydroxyvitamin D<sub>3</sub>Levels in Colorectal Cancer Patients and Associations with Physical Activity | 2.5 | 16 | Citations (PDF) |
| 212 | Physical activity and survival of colorectal cancer patients: Population‐based study from Germany | 4.5 | 53 | Citations (PDF) |
| 213 | Endothelial Notch1 Activity Facilitates Metastasis | 38.5 | 278 | Citations (PDF) |
| 214 | Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016) | 3.4 | 43 | Citations (PDF) |
| 215 | Meat intake and risk of colorectal polyps: results from a large population-based screening study in Germany, | 4.9 | 13 | Citations (PDF) |
| 216 | The association between microsatellite instability and lymph node count in colorectal cancer | 3.0 | 15 | Citations (PDF) |
| 217 | Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year | 1.9 | 10 | Citations (PDF) |
| 218 | Pre‐ and post‐diagnostic beta‐blocker use and prognosis after colorectal cancer: Results from a population‐based study | 4.5 | 32 | Citations (PDF) |
| 219 | Relationship of very low serum 25-hydroxyvitamin D3 levels with long-term survival in a large cohort of colorectal cancer patients from Germany | 6.1 | 55 | Citations (PDF) |
| 220 | Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia | 4.5 | 34 | Citations (PDF) |
| 221 | Colonoscopy and sigmoidoscopy use among older adults in different countries: A systematic review | 2.9 | 30 | Citations (PDF) |
| 222 | Associations of red and processed meat intake with major molecular pathological features of colorectal cancer | 6.1 | 38 | Citations (PDF) |
| 223 | Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study | 3.5 | 35 | Citations (PDF) |
| 224 | Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling | 6.1 | 45 | Citations (PDF) |
| 225 | Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer | 4.5 | 110 | Citations (PDF) |
| 226 | Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome | 2.4 | 10 | Citations (PDF) |
| 227 | Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data | 2.4 | 9 | Citations (PDF) |
| 228 | Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants | 2.4 | 8 | Citations (PDF) |
| 229 | SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients | 4.5 | 38 | Citations (PDF) |
| 230 | Beta blockers and cancer prognosis – The role of immortal time bias: A systematic review and meta-analysis | 9.8 | 79 | Citations (PDF) |
| 231 | Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany | 4.9 | 59 | Citations (PDF) |
| 232 | Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer | 4.9 | 53 | Citations (PDF) |
| 233 | Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer | 2.1 | 14 | Citations (PDF) |
| 234 | Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy | 4.5 | 14 | Citations (PDF) |
| 235 | No association of CpG island methylator phenotype and colorectal cancer survival: population-based study | 5.7 | 46 | Citations (PDF) |
| 236 | The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration | 13.9 | 54 | Citations (PDF) |
| 237 | Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review | 4.0 | 91 | Citations (PDF) |
| 238 | Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review | 2.9 | 13 | Citations (PDF) |
| 239 | Meat subtypes and their association with colorectal cancer: Systematic review and meta‐analysis | 4.5 | 138 | Citations (PDF) |
| 240 | Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment | 4.9 | 43 | Citations (PDF) |
| 241 | CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk | 5.7 | 22 | Citations (PDF) |
| 242 | Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk | 1.0 | 110 | Citations (PDF) |
| 243 | Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis | 2.9 | 67 | Citations (PDF) |
| 244 | Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer | 3.3 | 43 | Citations (PDF) |
| 245 | Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study | 1.7 | 18 | Citations (PDF) |
| 246 | Survival of patients with symptom- and screening-detected colorectal cancer | 1.7 | 85 | Citations (PDF) |
| 247 | Vorsorge-Koloskopie in Deutschland – Bilanz und Perspektiven | 0.0 | 0 | Citations (PDF) |
| 248 | Which adenomas are detected by fecal occult blood testing? A state‐wide analysis from <scp>B</scp>avaria, <scp>G</scp>ermany | 4.5 | 7 | Citations (PDF) |
| 249 | Lymph node count and prognosis in colorectal cancer: The influence of examination quality | 4.5 | 16 | Citations (PDF) |
| 250 | Overexpression of <scp>SIX1</scp> is an independent prognostic marker in stage <scp>I</scp>–<scp>III</scp> colorectal cancer | 4.5 | 37 | Citations (PDF) |
| 251 | Authors' reply: Meat subtypes and their association with colorectal cancer: Systematic review and meta‐analysis | 4.5 | 1 | Citations (PDF) |
| 252 | Smoking and survival of colorectal cancer patients: Population-based study from Germany | 4.5 | 52 | Citations (PDF) |
| 253 | Mendelian randomization study of height and risk of colorectal cancer | 5.1 | 58 | Citations (PDF) |
| 254 | Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach | 1.9 | 7 | Citations (PDF) |
| 255 | Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk | 1.2 | 81 | Citations (PDF) |
| 256 | Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopies | 5.1 | 39 | Citations (PDF) |
| 257 | Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy | 2.8 | 18 | Citations (PDF) |
| 258 | A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci | 1.0 | 136 | Citations (PDF) |
| 259 | Red Meat Intake, NAT2, and Risk of Colorectal Cancer: A Pooled Analysis of 11 Studies | 1.2 | 41 | Citations (PDF) |
| 260 | Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program | 1.0 | 137 | Citations (PDF) |
| 261 | Genome-wide association study of colorectal cancer identifies six new susceptibility loci | 13.9 | 155 | Citations (PDF) |
| 262 | Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment | 4.7 | 105 | Citations (PDF) |
| 263 | Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer | 2.8 | 22 | Citations (PDF) |
| 264 | Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants | 17.1 | 184 | Citations (PDF) |
| 265 | A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1 | 3.0 | 30 | Citations (PDF) |
| 266 | Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer | 2.9 | 29 | Citations (PDF) |
| 267 | Einführung eines organisierten Darmkrebs-Screenings in Deutschland: Chancen und Herausforderungen | 0.6 | 7 | Citations (PDF) |
| 268 | Genetic variants of adiponectin and risk of colorectal cancer | 4.5 | 16 | Citations (PDF) |
| 269 | Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany | 6.2 | 132 | Citations (PDF) |
| 270 | Gene–Environment Interaction Involving Recently Identified Colorectal Cancer Susceptibility Loci | 1.2 | 49 | Citations (PDF) |
| 271 | Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia | 21.2 | 36 | Citations (PDF) |
| 272 | Genome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer | 3.3 | 90 | Citations (PDF) |
| 273 | Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients | 4.5 | 114 | Citations (PDF) |
| 274 | Reply | 6.2 | 0 | Citations (PDF) |
| 275 | Stage‐specific associations between beta blocker use and prognosis after colorectal cancer | 4.1 | 93 | Citations (PDF) |
| 276 | Repeat polymorphisms in ESR2 and ARand colorectal cancer risk and prognosis: results from a German population-based case-control study | 3.1 | 19 | Citations (PDF) |
| 277 | Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies | 0.2 | 753 | Citations (PDF) |
| 278 | Incidence of Colorectal Adenomas: Birth Cohort Analysis among 4.3 Million Participants of Screening Colonoscopy | 1.2 | 55 | Citations (PDF) |
| 279 | Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin | 1.3 | 33 | Citations (PDF) |
| 280 | Comparisons of colorectal cancer mortality between screening participants and the general population are strongly biased unless an incidence-based mortality approach is used | 3.7 | 8 | Citations (PDF) |
| 281 | Estimating the heritability of colorectal cancer | 3.0 | 129 | Citations (PDF) |
| 282 | Smoking, Lower Gastrointestinal Endoscopy, and Risk for Colorectal Cancer | 1.2 | 12 | Citations (PDF) |
| 283 | Darmkrebsfrüherkennung | 1.4 | 8 | Citations (PDF) |
| 284 | Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy | 1.0 | 323 | Citations (PDF) |
| 285 | Men with negative results of guaiac‐based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results | 4.5 | 10 | Citations (PDF) |
| 286 | Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition | 5.1 | 21 | Citations (PDF) |
| 287 | Diagnostic Performance of Guaiac-Based Fecal Occult Blood Test in Routine Screening: State-Wide Analysis from Bavaria, Germany | 0.7 | 29 | Citations (PDF) |
| 288 | Mutations in POLE and survival of colorectal cancer patients – link to disease stage and treatment | 2.7 | 66 | Citations (PDF) |
| 289 | Development and Validation of a Scoring System to Identify Individuals at High Risk for Advanced Colorectal Neoplasms Who Should Undergo Colonoscopy Screening | 6.2 | 109 | Citations (PDF) |
| 290 | Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival | 6.7 | 42 | Citations (PDF) |
| 291 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals | 21.2 | 120 | Citations (PDF) |
| 292 | Colorectal cancers occurring after colonoscopy with polyp detection: Sites of polyps and sites of cancers | 4.5 | 14 | Citations (PDF) |
| 293 | Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality | 2.1 | 22 | Citations (PDF) |
| 294 | The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas | 8.8 | 22 | Citations (PDF) |
| 295 | Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies | 1.9 | 86 | Citations (PDF) |
| 296 | In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening | 3.7 | 26 | Citations (PDF) |
| 297 | Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis | 1.0 | 305 | Citations (PDF) |
| 298 | Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer | 1.2 | 30 | Citations (PDF) |
| 299 | Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study | 1.7 | 3 | Citations (PDF) |
| 300 | Colorectal Cancer Risk Associated with Hormone Use Varies by Expression of Estrogen Receptor-β | 0.6 | 50 | Citations (PDF) |
| 301 | Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study | 2.3 | 18 | Citations (PDF) |
| 302 | Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study | 1.2 | 52 | Citations (PDF) |
| 303 | Natural History of Colorectal Adenomas: Birth Cohort Analysis Among 3.6 Million Participants of Screening Colonoscopy | 1.2 | 108 | Citations (PDF) |
| 304 | Adherence to Physician Recommendations for Surveillance in Opportunistic Colorectal Cancer Screening: The Necessity of Organized Surveillance | 2.4 | 20 | Citations (PDF) |
| 305 | Inter-Physician Variation in Follow-Up Colonoscopies after Screening Colonoscopy | 2.4 | 13 | Citations (PDF) |
| 306 | Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility | 2.4 | 20 | Citations (PDF) |
| 307 | Darmkrebs-Screening | 0.2 | 0 | Citations (PDF) |
| 308 | Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer? | 3.4 | 5 | Citations (PDF) |
| 309 | Helicobacter pylori Infection and Colorectal Cancer Risk: Evidence From a Large Population-based Case-Control Study in Germany | 3.4 | 108 | Citations (PDF) |
| 310 | Interval cancers after negative colonoscopy: population-based case-control study | 21.2 | 174 | Citations (PDF) |
| 311 | Role of Colonoscopy and Polyp Characteristics in Colorectal Cancer After Colonoscopic Polyp Detection | 10.4 | 72 | Citations (PDF) |
| 312 | Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci | 0.6 | 157 | Citations (PDF) |
| 313 | Effect of Type 2 Diabetes Predisposing Genetic Variants on Colorectal Cancer Risk | 4.2 | 64 | Citations (PDF) |
| 314 | Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy | 2.5 | 51 | Citations (PDF) |
| 315 | Expression of oestrogen receptor β and prognosis of colorectal cancer | 5.7 | 105 | Citations (PDF) |
| 316 | Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases | 2.0 | 7 | Citations (PDF) |
| 317 | Beta blocker use and colorectal cancer risk | 4.1 | 54 | Citations (PDF) |
| 318 | A Comprehensive Investigation on Common Polymorphisms in the MDR1/ABCB1 Transporter Gene and Susceptibility to Colorectal Cancer | 2.4 | 34 | Citations (PDF) |
| 319 | Genome-Wide Search for Gene-Gene Interactions in Colorectal Cancer | 2.4 | 35 | Citations (PDF) |
| 320 | Protection From Colorectal Cancer After Colonoscopy | 10.4 | 731 | Citations (PDF) |
| 321 | Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database | 3.4 | 112 | Citations (PDF) |
| 322 | Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes | 3.9 | 26 | Citations (PDF) |
| 323 | Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort | 3.5 | 39 | Citations (PDF) |
| 324 | Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk | 2.9 | 16 | Citations (PDF) |
| 325 | Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk | 3.9 | 59 | Citations (PDF) |
| 326 | Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life | 5.7 | 133 | Citations (PDF) |
| 327 | Meta-analysis of new genome-wide association studies of colorectal cancer risk | 3.0 | 192 | Citations (PDF) |
| 328 | Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms | 10.4 | 48 | Citations (PDF) |
| 329 | Genetic Polymorphisms in
<i>GST</i>
Genes and Survival of Colorectal Cancer Patients Treated with Chemotherapy | 1.6 | 41 | Citations (PDF) |
| 330 | Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk | 4.5 | 17 | Citations (PDF) |
| 331 | Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer | 2.9 | 39 | Citations (PDF) |
| 332 | Colorectal cancer and polymorphisms in DNA repair genes WRN , RMI1 and BLM | 2.9 | 31 | Citations (PDF) |
| 333 | Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility | 2.9 | 58 | Citations (PDF) |
| 334 | Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study | 4.7 | 556 | Citations (PDF) |
| 335 | Male Sex and Smoking Have a Larger Impact on the Prevalence of Colorectal Neoplasia Than Family History of Colorectal Cancer | 6.2 | 85 | Citations (PDF) |
| 336 | Estimated long-term effects of the initial 6 years of the German screening colonoscopy program | 1.9 | 10 | Citations (PDF) |
| 337 | Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative Colonoscopy | 1.0 | 137 | Citations (PDF) |
| 338 | Genetic Polymorphisms in Genes Related to Oxidative Stress (<i>GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS</i>) and Survival of Rectal Cancer Patients after Radiotherapy | 0.7 | 26 | Citations (PDF) |
| 339 | Effect Modification by Smoking on the Association between Genetic Polymorphisms in Oxidative Stress Genes and Colorectal Cancer Risk | 1.2 | 23 | Citations (PDF) |
| 340 | Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: Estimates based on 1,875,708 screening colonoscopies | 5.1 | 65 | Citations (PDF) |
| 341 | Exposure to environmental tobacco smoke and the risk of colorectal cancer in a case–control study from Germany | 2.1 | 9 | Citations (PDF) |
| 342 | Screening: Prerequisites | 0.4 | 1 | Citations (PDF) |
| 343 | The association of cyclin D1 G870A and E‐cadherin C‐160A polymorphisms with the risk of colorectal cancer in a case control study and meta‐analysis | 4.5 | 38 | Citations (PDF) |
| 344 | Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology | 5.7 | 21 | Citations (PDF) |
| 345 | Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer | 26.1 | 506 | Citations (PDF) |
| 346 | Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany | 5.7 | 26 | Citations (PDF) |
| 347 | Case-Control Study Supports Extension of Surveillance Interval After Colonoscopic Polypectomy to at Least 5 Yr | 0.7 | 43 | Citations (PDF) |
| 348 | Gender differences in colorectal cancer: implications for age at initiation of screening | 5.7 | 210 | Citations (PDF) |
| 349 | Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study | 1.2 | 42 | Citations (PDF) |
| 350 | Validity of Self-Reported Endoscopies of the Large Bowel and Implications for Estimates of Colorectal Cancer Risk | 3.4 | 53 | Citations (PDF) |
| 351 | The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk | 2.9 | 14 | Citations (PDF) |
| 352 | Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene–environment interaction? | 1.3 | 35 | Citations (PDF) |
| 353 | Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: Evidence from a case-control study in Germany | 5.1 | 33 | Citations (PDF) |
| 354 | Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies | 21.2 | 379 | Citations (PDF) |
| 355 | Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case–control study | 4.5 | 75 | Citations (PDF) |
| 356 | Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer | 2.2 | 43 | Citations (PDF) |
| 357 | ARLTS1 variants and risk of colorectal cancer | 8.8 | 24 | Citations (PDF) |
| 358 | Cigarette smoking and colorectal cancer risk in Germany: A population-based case–control study | 4.5 | 36 | Citations (PDF) |
| 359 | Effect of <i>NAT1</i> and <i>NAT2</i> Genetic Polymorphisms on Colorectal Cancer Risk Associated with Exposure to Tobacco Smoke and Meat Consumption | 1.2 | 144 | Citations (PDF) |
| 360 | Death Receptor 4 Variants and Colorectal Cancer Risk | 1.2 | 34 | Citations (PDF) |
| 361 | Complication Rates in Colonoscopy Screening for Cancer | 0.1 | 28 | Citations (PDF) |
| 362 | Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis | 0.1 | 24 | Citations (PDF) |
| 363 | Incidence and Mortality of Proximal and Distal Colorectal Cancer in Germany | 0.1 | 37 | Citations (PDF) |
| 364 | Earlier screening colonoscopy in men: additional screening is needed at older ages | 0.1 | 3 | Citations (PDF) |
| 365 | Correspondence | 0.1 | 0 | Citations (PDF) |
| 366 | Eight Years of Colonoscopic Bowel Cancer Screening in Germany | 0.1 | 40 | Citations (PDF) |
| 367 | Declining Bowel Cancer Incidence and Mortality in Germany: An Analysis of Time Trends in the First Ten Years After the Introduction of Screening Colonoscopy | 0.1 | 86 | Citations (PDF) |
| 368 | Screening for Bowel Cancer: Increasing Participation via Personal Invitation | 0.1 | 34 | Citations (PDF) |
| 369 | Should Screening Colonoscopy Be Offered From Age 50? | 0.1 | 21 | Citations (PDF) |
| 370 | The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing | 0.1 | 17 | Citations (PDF) |
| 371 | Topography of cancer-associated immune cells in human solid tumors | 1.6 | 255 | Citations (PDF) |
| 372 | In Reply | 0.1 | 0 | Citations (PDF) |
| 373 | Substantiated Modelling Instead of Flying Blind | 0.1 | 0 | Citations (PDF) |
| 374 | In Reply | 0.1 | 0 | Citations (PDF) |
| 375 | In Reply | 0.1 | 0 | Citations (PDF) |
